Loading...
Cell death, inflammation, tumor burden, and proliferation blood biomarkers predict lung cancer radiotherapy response and correlate with tumor volume and proliferation imaging.
Salem, Ahmed Mistry, H Backen, Alison C Hodgson, Clare Koh, Pek K Dean, E Priest, Lynsey Haslett, Kate Trigonis, I Jackson, A
Salem, Ahmed
Mistry, H
Backen, Alison C
Hodgson, Clare
Koh, Pek K
Dean, E
Priest, Lynsey
Haslett, Kate
Trigonis, I
Jackson, A
Citations
Altmetric:
Abstract
There is an unmet need to develop noninvasive biomarkers to stratify patients in drug-radiotherapy trials. In this pilot study we investigated lung cancer radiotherapy response and toxicity blood biomarkers and correlated findings with tumor volume and proliferation imaging.
Description
Date
2017-12-11
Publisher
Collections
Files
Keywords
Type
Article
Citation
Cell death, inflammation, tumor burden, and proliferation blood biomarkers predict lung cancer radiotherapy response and correlate with tumor volume and proliferation imaging. 2017, Clin Lung Cancer